Celebrating 20 Years of AFTD’s Pilot Grant Program

Title Graphic: Celebrating 20 Years of AFTD’s Pilot Grant Program

Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock and a small group of medical advisors awarded $35,000 to Eileen Bigio, MD, a clinical researcher at Northwestern University, to identify abnormal proteins present in…

Read More

Celebrating 20 Years of AFTD’s Pilot Grant Program

Title Graphic: Celebrating 20 Years of AFTD’s Pilot Grant Program

Over the past 20 years, AFTD’s Pilot Grant program, which supports early-career researchers or new ideas, has funded $2.8 million in innovative FTD research. In 2005, AFTD founder Helen-Ann Comstock and a small group of medical advisors awarded $35,000 to Eileen Bigio, MD, a clinical researcher at Northwestern University, to identify abnormal proteins present in…

Read More

Advancing Hope: FTD and ALS Joint Initiatives

Text: Advancing Hope - FTD and ALS Joint Initiatives | Background: A doctor shows a tablet with an MRI result to a patient

Did you know that certain cellular changes that occur in FTD are also observed in Amyotrophic Lateral Sclerosis (ALS)? In some cases, neurodegeneration in ALS and FTD is linked to aggregation and impairment of a protein known as TDP-43. Furthermore, there are genetic mutations linked to onset of one or both diseases. With these and…

Read More

The Lived Experience of FTD: Managing Anxiety

Text: The Lived Experience of FTD - Managing Anxiety | Background: A woman sits leaning against the foot of her bed in contemplation

The following article was written by Chris Tann, a member of AFTD’s Persons With FTD Advisory Council. You can learn more about Chris and the other members of the Council on AFTD’s website. Anxiety is something that people living with FTD may experience on their journey. I have not been in the company of anyone,…

Read More

Two Drugs Selected for Evaluation in Platform Trial for PSP

Title: Two Drugs Selected for Evaluation in Platform Trial for PSP | Background: A team of scientists work in a lab - two discuss their work while the third uses a microscope

A pair of drugs has been selected for evaluation in a platform trial that aims to accelerate the development of treatments for progressive supranuclear palsy (PSP). The trial is being conducted by researchers at the University of California, San Francisco; the University of California, San Diego; and Massachusetts General Hospital. Drugs for Other Tauopathies Might…

Read More

Dear HelpLine: Hospice Care and FTD

Text: Dear HelpLine - Hospice Care for FTD | Background: A healthcare provider holds someone's hands during an appointment

Dear HelpLine, My sister has had FTD for a few years, and her doctor recently told us we should consider moving her to hospice. What does hospice care involve? How has the experience gone for others? Hospice offers holistic care that focuses on maximizing the quality of one’s remaining life by addressing physical symptoms and…

Read More